STIGNANI, Marina
 Distribuzione geografica
Continente #
NA - Nord America 3.803
AS - Asia 2.267
EU - Europa 998
SA - Sud America 262
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 7.358
Nazione #
US - Stati Uniti d'America 3.739
CN - Cina 1.039
SG - Singapore 716
UA - Ucraina 249
DE - Germania 235
BR - Brasile 226
HK - Hong Kong 161
TR - Turchia 141
GB - Regno Unito 111
VN - Vietnam 101
IT - Italia 97
FI - Finlandia 83
RU - Federazione Russa 55
SE - Svezia 43
FR - Francia 35
CA - Canada 34
MX - Messico 24
ID - Indonesia 21
PL - Polonia 21
IN - India 18
BD - Bangladesh 15
BE - Belgio 14
ES - Italia 13
AR - Argentina 11
IQ - Iraq 11
NL - Olanda 11
JP - Giappone 10
AE - Emirati Arabi Uniti 9
ZA - Sudafrica 9
LT - Lituania 7
VE - Venezuela 6
CO - Colombia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
MA - Marocco 4
PY - Paraguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
IE - Irlanda 3
IL - Israele 3
KE - Kenya 3
MD - Moldavia 3
PH - Filippine 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
GR - Grecia 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PK - Pakistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AT - Austria 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
LY - Libia 1
MW - Malawi 1
NO - Norvegia 1
OM - Oman 1
SA - Arabia Saudita 1
SI - Slovenia 1
YT - Mayotte 1
Totale 7.358
Città #
Hangzhou 437
Singapore 404
Woodbridge 400
Fairfield 347
Ashburn 329
Chandler 284
Jacksonville 274
Houston 238
Beijing 236
Santa Clara 188
Hong Kong 161
Seattle 139
Ann Arbor 138
Wilmington 122
Cambridge 111
New York 98
Nanjing 73
Izmir 72
Los Angeles 66
Princeton 55
Munich 49
Boardman 48
Dallas 47
Ho Chi Minh City 36
San Diego 32
Shanghai 32
Milan 28
Shenyang 27
Hebei 26
Turku 24
Dearborn 22
Hanoi 22
Mexico City 20
Bremen 19
Warsaw 19
Nanchang 16
São Paulo 16
Brussels 14
Falkenstein 14
Jiaxing 14
Addison 13
Brooklyn 13
Montreal 13
Hefei 12
London 12
Stockholm 12
Washington 12
Buffalo 11
Orem 11
Ferrara 10
Tianjin 10
Changsha 9
Chicago 9
Denver 9
Falls Church 9
Guangzhou 9
Helsinki 9
Mountain View 9
San Mateo 9
Tokyo 9
Toronto 9
Chennai 8
Jakarta 8
Jinan 8
Norwalk 8
Phoenix 8
Atlanta 7
Bologna 7
Boston 7
Brasília 7
Amsterdam 6
Augusta 6
Campinas 6
Dong Ket 6
Frankfurt am Main 6
Johannesburg 6
Manchester 6
Moscow 6
Zhengzhou 6
Baghdad 5
Curitiba 5
Indiana 5
Lanzhou 5
Ningbo 5
Recife 5
Taizhou 5
Verona 5
Ankara 4
Auburn Hills 4
Bandung 4
Belo Horizonte 4
Charlotte 4
Des Moines 4
Elk Grove Village 4
Haiphong 4
Kunming 4
Ninh Bình 4
Orange 4
Poplar 4
Rio de Janeiro 4
Totale 5.130
Nome #
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 398
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 278
HLA-G MOLECULES ARE COSTITUTIVELY EXPRESSED BY HUMAN SYNOVIAL FIBROBLASTS AND UP-MODULATED IN OSTEOARTHRITIS 267
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 225
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 215
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 194
Emerging topics and new perspectives on HLA-G 189
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 184
HLA-G expression is a fundamental prerequisite to pregnancy 179
Decreased production of human leukocyte antigen G molecules in sinonasal polyposis 170
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 165
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 155
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 152
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 149
Release of sICAM-1 in oocytes and in vitro fertilized human embryos 146
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 144
Allergic women have reduced sHLA-G plasma levels at delivery 141
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 141
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 141
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 135
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 133
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 130
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 129
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 126
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 125
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 123
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 121
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 116
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 114
Implication of immunosoppressive molecules during human oocyte maturation 107
The possible role of HLA-G molecules in human oocyte/embryo secretome 107
Potential role of soluble HLA-G molecules in multiple sclerosis 104
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 102
null 95
Production of soluble HLA-G molecules by mesenchymal stromal cells after in vitro IL-10 activation: a marker for “a priori” evaluation of their immunoregulatory activity 95
Production of solubile HLA-G antigens by bone marrow - derived human mesenchimal cells (B-MSCS) has a role in the inhibition of the lymphoproliferative response. 94
null 94
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 94
null 93
Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity 93
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. 93
Immunophenotypic heterogeneity of mesenchymal stromal cells: multiparametric flow cytometric analysis 92
null 92
null 90
Soluble Human Leukocyte Antigen-G Isoforms in Maternal Plasma in Early and Late Pregnancy 87
The role of HLA–G 14bp polymorphism in allogeneic haematopoietic stem cell transplantation after short-term course methotrexate for graft-versus host disease prophylaxis 85
HLA-G Polymorphism and Papillary Thyroid Cancer Histological Aggressiveness. 81
Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes 80
null 77
HLA-G and inflammatory diseases. 76
Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma 74
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism. 69
Ruolo funzionale degli antigeni solubili HLA-G nell’immunomodulazione mediata da cellule mesenchimali staminali 61
null 50
Umbilical cord blood CD34(+)cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functions. 50
Produzione di molecole solubili HLA-G da parte di cellule mesenchimali attivate in vitro con IL-10: un marker per la definizione “a priori” della capacità tolerogenica 50
Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. 49
null 47
null 46
null 45
Soluble HLA-G molecules in Umbilical Cord Blood plasma as a marker of immunoregulatory ability 44
null 31
Totale 7.432
Categoria #
all - tutte 32.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 56 11 66 4 79 105 32
2021/2022512 17 63 42 25 11 16 28 23 11 42 47 187
2022/2023603 61 40 15 91 118 83 28 57 73 4 25 8
2023/2024323 20 43 24 8 28 110 3 10 3 4 3 67
2024/20251.054 27 37 85 31 135 108 20 49 153 119 166 124
2025/20261.681 339 125 239 390 486 102 0 0 0 0 0 0
Totale 7.432